The average 12-month price target for BrainsWay has decreased by 4.53% from the previous average, which may indicate a slightly less optimistic outlook from analysts. However, the company still received 2 bullish and 2 somewhat bullish ratings in the last quarter, suggesting that analysts remain positive about the stock's potential. This could lead to a short-term increase in the stock price.